| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2006, p. 3917-3919, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00747-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Schering-Plough Research Institute, 2015 Galloping Hill Road, 4700, Kenilworth, New Jersey 07033
Received 19 June 2006/ Returned for modification 15 July 2006/ Accepted 30 August 2006
Posaconazole and itraconazole were more potent inhibitors of ergosterol synthesis, in both intact cells and cell extracts from Absidia corymbifera and Rhizopus oryzae, than voriconazole and fluconazole. Similarly, expression of CYP51 from R. oryzae in Saccharomyces cerevisiae significantly increased resistance to fluconazole and voriconazole but not to posaconazole and itraconazole.
Published ahead of print on 11 September 2006.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |